Stay updated on Ipilimumab + Nivolumab w/Thoracic Radiotherapy Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab + Nivolumab w/Thoracic Radiotherapy Clinical Trial page.

Latest updates to the Ipilimumab + Nivolumab w/Thoracic Radiotherapy Clinical Trial page
- CheckyesterdayChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as new content related to radiation therapy and various types of proteins and antibodies. However, it has also removed several key topics related to lung cancer and immunological agents.SummaryDifference3%
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check22 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check29 days agoChange DetectedThe web page has been updated to version v2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference1.0%
- Check36 days agoChange DetectedThe page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about HHS Vulnerability Disclosure.SummaryDifference0.2%
- Check43 days agoChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.1%
Stay in the know with updates to Ipilimumab + Nivolumab w/Thoracic Radiotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab + Nivolumab w/Thoracic Radiotherapy Clinical Trial page.